Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Stereotactic radiation therapy for the treatment of functional pituitary adenomas associated with feline acromegaly.

Wormhoudt TL, Boss MK, Lunn K, Griffin L, Leary D, Dowers K, Rao S, LaRue SM.

J Vet Intern Med. 2018 Jul;32(4):1383-1391. doi: 10.1111/jvim.15212. Epub 2018 May 21.

2.

Outcome of 9 dogs treated with stereotactic radiation therapy for primary or metastatic vertebral osteosarcoma.

Swift KE, LaRue SM.

Vet Comp Oncol. 2018 Mar;16(1):E152-E158. doi: 10.1111/vco.12362. Epub 2017 Nov 27.

PMID:
29181871
3.

RETROSPECTIVE EVALUATION OF INTERFRACTION URETERAL MOVEMENT IN DOGS UNDERGOING RADIATION THERAPY TO ELUCIDATE APPROPRIATE SETUP MARGINS.

Yoshikawa H, Nolan MW, Lewis DW, Larue SM.

Vet Radiol Ultrasound. 2016 Mar-Apr;57(2):170-9. doi: 10.1111/vru.12309. Epub 2015 Dec 3.

PMID:
26634416
4.

DOSIMETRIC CONSEQUENCES OF USING CONTRAST-ENHANCED COMPUTED TOMOGRAPHIC IMAGES FOR INTENSITY-MODULATED STEREOTACTIC BODY RADIOTHERAPY PLANNING.

Yoshikawa H, Roback DM, Larue SM, Nolan MW.

Vet Radiol Ultrasound. 2015 Nov-Dec;56(6):687-95. doi: 10.1111/vru.12281. Epub 2015 Aug 4. Erratum in: Vet Radiol Ultrasound. 2016 May;57(3):352.

PMID:
26242716
5.

Pudendal nerve and internal pudendal artery damage may contribute to radiation-induced erectile dysfunction.

Nolan MW, Marolf AJ, Ehrhart EJ, Rao S, Kraft SL, Engel S, Yoshikawa H, Golden AE, Wasserman TH, LaRue SM.

Int J Radiat Oncol Biol Phys. 2015 Mar 15;91(4):796-806. doi: 10.1016/j.ijrobp.2014.12.025.

PMID:
25752394
6.

Predicting clinical outcome in feline oral squamous cell carcinoma: tumour initiating cells, telomeres and telomerase.

Yoshikawa H, Maranon DG, Battaglia CLR, Ehrhart EJ, Charles JB, Bailey SM, LaRue SM.

Vet Comp Oncol. 2016 Dec;14(4):371-383. doi: 10.1111/vco.12117. Epub 2014 Sep 11.

PMID:
25212092
7.

Advances in veterinary radiation therapy: targeting tumors and improving patient comfort.

LaRue SM, Custis JT.

Vet Clin North Am Small Anim Pract. 2014 Sep;44(5):909-23. doi: 10.1016/j.cvsm.2014.05.010. Review.

PMID:
25174907
8.

Comparison of adaptive radiotherapy techniques for external radiation therapy of canine bladder cancer.

Nieset JR, Harmon JF, Johnson TE, Larue SM.

Vet Radiol Ultrasound. 2014 Nov-Dec;55(6):644-50. doi: 10.1111/vru.12163. Epub 2014 May 16.

PMID:
24832931
9.

Stereotactic body radiation therapy for treatment of injection-site sarcomas in cats: 11 cases (2008-2012).

Nolan MW, Griffin LR, Custis JT, LaRue SM.

J Am Vet Med Assoc. 2013 Aug 15;243(4):526-31. doi: 10.2460/javma.243.4.526.

PMID:
23902446
10.

Assessment of predictive molecular variables in feline oral squamous cell carcinoma treated with stereotactic radiation therapy.

Yoshikawa H, Ehrhart EJ, Charles JB, Custis JT, LaRue SM.

Vet Comp Oncol. 2016 Mar;14(1):39-57. doi: 10.1111/vco.12050. Epub 2013 Jul 2.

11.

Evaluation of 18F-FDG PET/CT as a diagnostic imaging and staging tool for feline oral squamous cell carcinoma.

Randall EK, Kraft SL, Yoshikawa H, LaRue SM.

Vet Comp Oncol. 2016 Mar;14(1):28-38. doi: 10.1111/vco.12047. Epub 2013 Jun 19.

PMID:
23782408
12.

Accuracy of CT and MRI for contouring the feline optic apparatus for radiation therapy planning.

Nolan MW, Randall EK, LaRue SM, Lunn KF, Stewart J, Kraft SL.

Vet Radiol Ultrasound. 2013 Sep-Oct;54(5):560-6. doi: 10.1111/vru.12070. Epub 2013 Jun 6.

PMID:
23738866
13.

Comparison between 2-(18) F-fluoro-2-deoxy-d-glucose positron emission tomography and contrast-enhanced computed tomography for measuring gross tumor volume in cats with oral squamous cell carcinoma.

Yoshikawa H, Randall EK, Kraft SL, Larue SM.

Vet Radiol Ultrasound. 2013 May-Jun;54(3):307-13. doi: 10.1111/vru.12016. Epub 2013 Feb 27.

PMID:
23441633
14.

Orthotopic model of canine osteosarcoma in athymic rats for evaluation of stereotactic radiotherapy.

Schwartz AL, Custis JT, Harmon JF, Powers BE, Chubb LS, LaRue SM, Ehrhart NP, Ryan SD.

Am J Vet Res. 2013 Mar;74(3):452-8. doi: 10.2460/ajvr.74.3.452.

PMID:
23438123
15.

Immunohistochemical characterization of feline oral squamous cell carcinoma.

Yoshikawa H, Ehrhart EJ, Charles JB, Thamm DH, Larue SM.

Am J Vet Res. 2012 Nov;73(11):1801-6. doi: 10.2460/ajvr.73.11.1801.

PMID:
23106467
16.

Repeatability of a planning target volume expansion protocol for radiation therapy of regional lymph nodes in canine and feline patients with head tumors.

Yoshikawa H, Harmon JF, Custis JT, Larue SM.

Vet Radiol Ultrasound. 2012 Nov-Dec;53(6):667-72. doi: 10.1111/j.1740-8261.2012.01972.x. Epub 2012 Sep 18.

PMID:
22985251
17.

Intensity-modulated and image-guided radiation therapy for treatment of genitourinary carcinomas in dogs.

Nolan MW, Kogan L, Griffin LR, Custis JT, Harmon JF, Biller BJ, Larue SM.

J Vet Intern Med. 2012 Jul-Aug;26(4):987-95. doi: 10.1111/j.1939-1676.2012.00946.x. Epub 2012 May 25.

18.

Menhaden oil administration to dogs treated with radiation for nasal tumors demonstrates lower levels of tissue eicosanoids.

Hansen RA, Anderson C, Fettman MJ, Larue SM, Davenport DJ, Gross KL, Richardson KL, Ogilvie GK.

Nutr Res. 2011 Dec;31(12):929-36. doi: 10.1016/j.nutres.2011.09.018.

PMID:
22153519
19.

Use of cone-beam computed tomography to characterize daily urinary bladder variations during fractionated radiotherapy for canine bladder cancer.

Nieset JR, Harmon JF, Larue SM.

Vet Radiol Ultrasound. 2011 Sep-Oct;52(5):580-8. doi: 10.1111/j.1740-8261.2011.01838.x. Epub 2011 Jun 23.

PMID:
21699616
20.

Abdominal irradiation as a rescue therapy for feline gastrointestinal lymphoma: a retrospective study of 11 cats (2001-2008).

Parshley DL, Larue SM, Kitchell B, Heller D, Dhaliwal RS.

J Feline Med Surg. 2011 Feb;13(2):63-8. doi: 10.1016/j.jfms.2010.07.017. Epub 2011 Jan 7.

PMID:
21216169
21.
22.

Radiotherapy and surgery for feline soft tissue sarcoma.

Mayer MN, Treuil PL, LaRue SM.

Vet Radiol Ultrasound. 2009 Nov-Dec;50(6):669-72.

PMID:
19999355
23.

Correlations between numerical chromosomal aberrations in the tumor and peripheral blood in canine lymphoma.

Devitt JJ, Maranon DG, Ehrhart EJ, Bachand AM, Lana SE, LaRue SM.

Cytogenet Genome Res. 2009;124(1):12-8. doi: 10.1159/000200083. Epub 2009 Apr 15.

24.

Induction of the human heat shock promoter HSP70B by nutritional stress: implications for cancer gene therapy.

Siddiqui F, Avery PR, Li CY, Zhang X, LaRue SM, Dewhirst MW, Ullrich RL.

Cancer Invest. 2008 Jul;26(6):553-61. doi: 10.1080/07357900701788015.

PMID:
18584345
25.

Correlations between acute radiation scores and pain scores in canine radiation patients with cancer of the forelimb.

Carsten RE, Hellyer PW, Bachand AM, LaRue SM.

Vet Anaesth Analg. 2008 Jul;35(4):355-62. doi: 10.1111/j.1467-2995.2008.00396.x. Epub 2008 May 5.

PMID:
18466168
26.

Hyperthermia induces endoplasmic reticulum-mediated apoptosis in melanoma and non-melanoma skin cancer cells.

Shellman YG, Howe WR, Miller LA, Goldstein NB, Pacheco TR, Mahajan RL, LaRue SM, Norris DA.

J Invest Dermatol. 2008 Apr;128(4):949-56. Epub 2007 Nov 8.

27.

Effects of palliative radiation therapy on nonsplenic hemangiosarcoma in dogs.

Hillers KR, Lana SE, Fuller CR, LaRue SM.

J Am Anim Hosp Assoc. 2007 Jul-Aug;43(4):187-92.

PMID:
17615398
28.

Design considerations for incorporating sodium iodide symporter reporter gene imaging into prostate cancer gene therapy trials.

Siddiqui F, Barton KN, Stricker HJ, Steyn PF, Larue SM, Karvelis KC, Sparks RB, Kim JH, Brown SL, Freytag SO.

Hum Gene Ther. 2007 Apr;18(4):312-22.

PMID:
17408358
29.

A phase I trial of hyperthermia-induced interleukin-12 gene therapy in spontaneously arising feline soft tissue sarcomas.

Siddiqui F, Li CY, Larue SM, Poulson JM, Avery PR, Pruitt AF, Zhang X, Ullrich RL, Thrall DE, Dewhirst MW, Hauck ML.

Mol Cancer Ther. 2007 Jan;6(1):380-9.

30.

Anti-angiogenic effects of interleukin-12 delivered by a novel hyperthermia induced gene construct.

Siddiqui F, Ehrhart EJ, Charles B, Chubb L, Li CY, Zhang X, Larue SM, Avery PR, Dewhirst MW, Ullrich RL.

Int J Hyperthermia. 2006 Nov;22(7):587-606.

PMID:
17079216
31.

Outcomes of pituitary tumor irradiation in cats.

Mayer MN, Greco DS, LaRue SM.

J Vet Intern Med. 2006 Sep-Oct;20(5):1151-4.

32.

Changes in tumour oxygenation during fractionated hyperthermia and radiation therapy in spontaneous canine sarcomas.

Thrall DE, Larue SM, Pruitt AF, Case B, Dewhirst MW.

Int J Hyperthermia. 2006 Aug;22(5):365-73.

PMID:
16891239
33.

Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors.

Hauck ML, LaRue SM, Petros WP, Poulson JM, Yu D, Spasojevic I, Pruitt AF, Klein A, Case B, Thrall DE, Needham D, Dewhirst MW.

Clin Cancer Res. 2006 Jul 1;12(13):4004-10.

34.

Characterization of a recombinant adenovirus vector encoding heat-inducible feline interleukin-12 for use in hyperthermia-induced gene-therapy.

Siddiqui F, Li CY, Zhang X, Larue SM, Dewhirst MW, Ullrich RL, Avery PR.

Int J Hyperthermia. 2006 Mar;22(2):117-34.

PMID:
16754596
35.

Soft tissue sarcomas in dogs.

Mayer MN, LaRue SM.

Can Vet J. 2005 Nov;46(11):1048, 1050, 1052. Review. No abstract available.

36.

Radiation therapy in the treatment of canine lymphoma.

Mayer MN, Larue SM.

Can Vet J. 2005 Sep;46(9):842-4. Review. No abstract available.

37.

Thermal dose is related to duration of local control in canine sarcomas treated with thermoradiotherapy.

Thrall DE, LaRue SM, Yu D, Samulski T, Sanders L, Case B, Rosner G, Azuma C, Poulson J, Pruitt AF, Stanley W, Hauck ML, Williams L, Hess P, Dewhirst MW.

Clin Cancer Res. 2005 Jul 15;11(14):5206-14.

38.

Studies of a vascular-acting photosensitizer, Pd-bacteriopheophorbide (Tookad), in normal canine prostate and spontaneous canine prostate cancer.

Huang Z, Chen Q, Luck D, Beckers J, Wilson BC, Trncic N, Larue SM, Blanc D, Hetzel FW.

Lasers Surg Med. 2005 Jun;36(5):390-7.

39.

Radiation therapy for the treatment of urethral sarcoma in a cria.

Gustafson NR, Severidt J, Van Metre DC, Schultheiss PC, Larue SM, Callan RJ.

J Vet Intern Med. 2005 Mar-Apr;19(2):271-4. No abstract available.

40.

Curative-intent radiation therapy as a treatment modality for appendicular and axial osteosarcoma: a preliminary retrospective evaluation of 14 dogs with the disease.

Walter CU, Dernell WS, LaRue SM, Lana SE, Lafferty MH, LaDue TA, Withrow SJ.

Vet Comp Oncol. 2005 Mar;3(1):1-7. doi: 10.1111/j.1476-5810.2005.00062.x.

PMID:
19379208
41.

Use of radiation and a slow-release cisplatin formulation for treatment of canine nasal tumors.

Lana SE, Dernell WS, Lafferty MH, Withrow SJ, LaRue SM.

Vet Radiol Ultrasound. 2004 Nov-Dec;45(6):577-81.

PMID:
15605853
42.

Cobalt radiation with or without low-dose cisplatin for treatment of canine naso-sinus carcinomas.

Nadeau ME, Kitchell BE, Rooks RL, LaRue SM.

Vet Radiol Ultrasound. 2004 Jul-Aug;45(4):362-7.

PMID:
15373266
43.

Transurethral resection in the management of urethral and prostatic neoplasia in 6 dogs.

Liptak JM, Brutscher SP, Monnet E, Dernell WS, Twedt DC, Kazmierski KJ, Walter CU, Mullins MN, Larue SM, Withrow SJ.

Vet Surg. 2004 Sep-Oct;33(5):505-16.

PMID:
15362989
44.

Intraoperative extracorporeal irradiation for limb sparing in 13 dogs.

Liptak JM, Dernell WS, Lascelles BD, Larue SM, Jameson VJ, Powers BE, Huber DJ, Withrow SJ.

Vet Surg. 2004 Sep-Oct;33(5):446-56.

PMID:
15362983
45.

A preliminary assessment of whole-body radiotherapy interposed within a chemotherapy protocol for canine lymphoma.

Gustafson NR, Lana SE, Mayer MN, LaRue SM.

Vet Comp Oncol. 2004 Sep;2(3):125-31. doi: 10.1111/j.1476-5810.2004.00046.x.

PMID:
19379300
46.

Effect of calcitonin gene related peptide vs sodium nitroprusside to increase temperature in spontaneous canine tumours during local hyperthermia.

Poulson JM, Vujaskovic Z, Gaskin AA, Larue SM, Meyer RE, Prescott DM, Samulski TV, Thrall DE, Dewhirst MW.

Int J Hyperthermia. 2004 Aug;20(5):477-89.

PMID:
15277021
47.

Effects of Pd-bacteriopheophorbide (TOOKAD)-mediated photodynamic therapy on canine prostate pretreated with ionizing radiation.

Huang Z, Chen Q, Trncic N, LaRue SM, Brun PH, Wilson BC, Shapiro H, Hetzel FW.

Radiat Res. 2004 Jun;161(6):723-31.

48.

Evaluation of cisplatin in combination with a biologic response modifier in a murine mammary carcinoma model.

Morello E, Dernell WS, Kuntz CA, LaRue SM, Lafferty M, Nelson A, Brekke JH, Mallinckrodt CH, Withrow SJ, Manning MC.

Cancer Invest. 2002;20(4):480-9.

PMID:
12094543
49.

Late complications of pelvic irradiation in 16 dogs.

Anderson CR, McNiel EA, Gillette EL, Powers BE, LaRue SM.

Vet Radiol Ultrasound. 2002 Mar-Apr;43(2):187-92.

PMID:
11954816
50.

Radiation therapy in the treatment of canine and feline thymomas: a retrospective study (1985-1999).

Smith AN, Wright JC, Brawner WR Jr, LaRue SM, Fineman L, Hogge GS, Kitchell BE, Hohenhaus AE, Burk RL, Dhaliwal RS, Duda LE.

J Am Anim Hosp Assoc. 2001 Sep-Oct;37(5):489-96.

PMID:
11563450

Supplemental Content

Loading ...
Support Center